Exact Sciences Corporation
EXAS
$46.35
$0.461.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.29% | 12.78% | 12.41% | 5.82% | 16.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.29% | 12.78% | 12.41% | 5.82% | 16.98% |
| Cost of Revenue | 11.34% | 16.34% | 20.93% | 8.44% | 73.41% |
| Gross Profit | 9.60% | 11.48% | 9.53% | 4.90% | -3.48% |
| SG&A Expenses | 12.40% | 1.91% | -6.59% | 4.04% | -3.81% |
| Depreciation & Amortization | -3.21% | 6.28% | 1.67% | 1.67% | -400.47% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.79% | 3.60% | 3.25% | 6.61% | 3.08% |
| Operating Income | 14.68% | 74.85% | 71.32% | -12.12% | 64.07% |
| Income Before Tax | -1,638.86% | -3,688.49% | 82.05% | -49.56% | 61.23% |
| Income Tax Expenses | -1,765.74% | 224.50% | 32.16% | 8.99% | 72.04% |
| Earnings from Continuing Operations | -1,637.30% | -4,915.62% | 80.49% | -48.65% | 61.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,637.30% | -4,915.62% | 80.49% | -48.65% | 61.04% |
| EBIT | 14.68% | 74.85% | 71.32% | -12.12% | 64.07% |
| EBITDA | 38.38% | 270.41% | 219.87% | -17.16% | 120.09% |
| EPS Basic | -1,597.82% | -4,802.27% | 80.92% | -45.59% | 61.80% |
| Normalized Basic EPS | -43.38% | 79.64% | 75.05% | -4.80% | 80.65% |
| EPS Diluted | -1,600.69% | -4,983.72% | 80.92% | -45.59% | 61.80% |
| Normalized Diluted EPS | -43.38% | 79.25% | 75.05% | -4.80% | 80.65% |
| Average Basic Shares Outstanding | 2.32% | 2.30% | 2.28% | 2.11% | 1.99% |
| Average Diluted Shares Outstanding | 2.32% | 0.39% | 2.28% | 2.11% | 1.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
